1. The Prevalence and Determinants of NAFLD and MAFLD and Their Severity in the VA Primary Care Setting
- Author
-
Thrift, Aaron P, Nguyen, Theresa H, Pham, Codey, Balakrishnan, Maya, Kanwal, Fasiha, Loomba, Rohit, Duong, Hao T, Ramsey, David, and El-Serag, Hashem B
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Chronic Liver Disease and Cirrhosis ,Cardiovascular ,Nutrition ,Clinical Research ,Hepatitis ,Liver Disease ,Digestive Diseases ,Good Health and Well Being ,Humans ,Female ,Middle Aged ,Male ,Non-alcoholic Fatty Liver Disease ,Prevalence ,Cross-Sectional Studies ,Risk Factors ,Primary Health Care ,Fatty Liver ,Liver Cancer ,Obesity ,Veterans ,Gastroenterology & Hepatology ,Clinical sciences - Abstract
Background & aimsA recent panel of international experts proposed the disease acronym metabolic (dysfunction)-associated fatty liver disease (MAFLD) in lieu of nonalcoholic fatty liver disease (NAFLD). We aimed to estimate the burden of and risk factors for NAFLD and MAFLD, and to examine the concordance between definitions in a Veterans population.MethodsWe conducted a cross-sectional study among randomly selected patients within primary care at the Houston Veterans Affairs (VA) facility. Participants completed a survey, provided blood, and underwent Fibroscan. In the absence of heavy alcohol, hepatitis C virus and hepatitis B virus, a controlled attenuation parameter median ≥290 dB/m was used to define NAFLD, whereas MAFLD was defined as controlled attenuation parameter median ≥290 dB/m and either body mass index ≥25 kg/m2 or diabetes, or 2 or more of the following: hypertension, high triglycerides, low high-density lipoprotein cholesterol, and high low-density lipoprotein cholesterol.ResultsThe mean age of participants was 50.9 years, 55.4% were women, 42.8% were white, and 43.8% were Black. The prevalence of NAFLD was 40.6% (82/202). All 82 patients with NAFLD had a body mass index ≥25 kg/m2, and therefore met our criteria for MAFLD (ie, 100% concordance). Compared with patients with no metabolic trait, patients with ≥3 traits had a 48-fold (adjusted odds ratio, 47.6; 95% confidence interval, 11.3-200) higher risk of NAFLD/MAFLD. Overall, 19 participants (9.4% of the total, 15.9% of those with NAFLD) had at least moderate fibrosis.ConclusionsNAFLD was present in 40% of Veterans registered in primary care; 9.4% of veterans had at least moderate hepatic fibrosis, with most having concurrent NAFLD. There was perfect concordance between NAFLD and the alternative MAFLD definition.
- Published
- 2023